Allermi
PrivateLast Round
Seed
Mar 16, 2023
Total Funding Raised
$4.75M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Allermi operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in March 2023.
Allermi is a healthtech company that provides a direct-to-consumer telehealth service for customized prescription nasal sprays to treat allergy symptoms.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, D2C Brands, Subscription Commerce, Patient Engagement
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allermi Comparables
Compare Allermi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nectar | 85% | |
| Curex | 81% | |
| Wyndly | 78% |
For institutional investors. Book with your work email.
Allermi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 16, 2023 | ||||
| Pre Seed | Sep 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Allermi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FourSight Capital Partners | Seed |
| Lucas Venture Group | Pre Seed |
| Nelstone Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM.
- May 18, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
Allermi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allermi's valuation, stock price, and market status.
Is Allermi a public or private company?
Allermi is a private company.
What is the current stock price of Allermi?
Allermi is a private company, so its shares have no public market price. Caplight tracks Allermi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allermi worth (valuation)?
Valuation information for Allermi is not publicly available.
Can I buy Allermi stock?
Allermi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allermi's last funding round?
Allermi's most recent funding round was Seed on March 16, 2023.
Who are the main investors in Allermi?
Key investors in Allermi include Lucas Venture Group, Nelstone Ventures.
Will Allermi IPO soon?
No public IPO plans have been announced for Allermi.
How can I track Allermi secondary market activity?
Caplight tracks bids, offers, and trades in Allermi's shares on secondary markets.